BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24530429)

  • 1. Illegitimate V(D)J recombination-mediated deletions in Notch1 and Bcl11b are not sufficient for extensive clonal expansion and show minimal age or sex bias in frequency or junctional processing.
    Champagne DP; Shockett PE
    Mutat Res; 2014 Mar; 761():34-48. PubMed ID: 24530429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
    Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
    Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development.
    Murray JM; O'Neill JP; Messier T; Rivers J; Walker VE; McGonagle B; Trombley L; Cowell LG; Kelsoe G; McBlane F; Finette BA
    J Immunol; 2006 Oct; 177(8):5393-404. PubMed ID: 17015725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy.
    Onozawa M; Aplan PD
    Genes Chromosomes Cancer; 2012 Jun; 51(6):525-35. PubMed ID: 22334400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of V(D)J recombinase in the generation of intragenic deletions in the Rit1/Bcl11b tumor suppressor gene in gamma-ray-induced thymic lymphomas and in normal thymus of the mouse.
    Sakata J; Inoue J; Ohi H; Kosugi-Okano H; Mishima Y; Hatakeyama K; Niwa O; Kominami R
    Carcinogenesis; 2004 Jun; 25(6):1069-75. PubMed ID: 14754877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.
    Meissner B; Bartram T; Eckert C; Trka J; Panzer-Grümayer R; Hermanova I; Ellinghaus E; Franke A; Möricke A; Schrauder A; Teigler-Schlegel A; Dörge P; von Stackelberg A; Basso G; Bartram CR; Kirschner-Schwabe R; Bornhäuser B; Bourquin JP; Cazzaniga G; Hauer J; Attarbaschi A; Izraeli S; Zaliova M; Cario G; Zimmermann M; Avigad S; Sokalska-Duhme M; Metzler M; Schrappe M; Koehler R; Te Kronnie G; Stanulla M
    Hum Mol Genet; 2014 Feb; 23(3):590-601. PubMed ID: 24045615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell of origin in radiation-induced premalignant thymocytes with differentiation capability in mice conditionally losing one Bcl11b allele.
    Go R; Hirose S; Katsuragi Y; Obata M; Abe M; Mishima Y; Sakimura K; Kominami R
    Cancer Sci; 2013 Aug; 104(8):1009-16. PubMed ID: 23663453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.
    Kraszewska MD; Dawidowska M; Kosmalska M; Sędek L; Grzeszczak W; Kowalczyk JR; Szczepański T; Witt M;
    Blood Cells Mol Dis; 2013 Jan; 50(1):33-8. PubMed ID: 23040356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl11b heterozygosity promotes clonal expansion and differentiation arrest of thymocytes in gamma-irradiated mice.
    Go R; Hirose S; Morita S; Yamamoto T; Katsuragi Y; Mishima Y; Kominami R
    Cancer Sci; 2010 Jun; 101(6):1347-53. PubMed ID: 20384631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of illegitimate TCRbeta/gamma gene recombination in human lymphocytes: influence of age, environmental exposure and cytostatic treatment, and correlation with frequencies of t(14;18) and hprt mutation.
    Meydan D; Nilsson T; Törnblom M; Hagmar L; Hellgren D; Fuscoe JC; Lambert B
    Mutat Res; 1999 Aug; 444(2):393-403. PubMed ID: 10521679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
    Ehrlich LA; Yang-Iott K; Bassing CH
    Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Quantification of t(14;18) and HPRT Exon 2/3 Deletions in Human Lymphocytes.
    Fuscoe JC
    Methods Mol Biol; 2020; 2102():361-370. PubMed ID: 31989567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
    Fuscoe JC
    Methods Mol Biol; 2014; 1105():303-11. PubMed ID: 24623238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of TCR alpha beta partly rescues developmental arrest and apoptosis of alpha beta T cells in Bcl11b-/- mice.
    Inoue J; Kanefuji T; Okazuka K; Watanabe H; Mishima Y; Kominami R
    J Immunol; 2006 May; 176(10):5871-9. PubMed ID: 16670294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development.
    Dolens AC; Durinck K; Lavaert M; Van der Meulen J; Velghe I; De Medts J; Weening K; Roels J; De Mulder K; Volders PJ; De Preter K; Kerre T; Vandekerckhove B; Leclercq G; Vandesompele J; Mestdagh P; Van Vlierberghe P; Speleman F; Taghon T
    EMBO Rep; 2020 May; 21(5):e49006. PubMed ID: 32255245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
    Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
    Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD5
    Hatano S; Murakami T; Noguchi N; Yamada H; Yoshikai Y
    Cell Rep; 2017 Oct; 21(5):1191-1202. PubMed ID: 29091759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-Target V(D)J Recombination Drives Lymphomagenesis and Is Escalated by Loss of the Rag2 C Terminus.
    Mijušković M; Chou YF; Gigi V; Lindsay CR; Shestova O; Lewis SM; Roth DB
    Cell Rep; 2015 Sep; 12(11):1842-52. PubMed ID: 26365182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VDJ recombinase-mediated TCR β locus gene usage and coding joint processing in peripheral T cells during perinatal and pediatric development.
    Murray JM; Messier T; Rivers J; O'Neill JP; Walker VE; Vacek PM; Finette BA
    J Immunol; 2012 Sep; 189(5):2356-64. PubMed ID: 22855706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans.
    Fuscoe JC; Vira LK; Collard DD; Moore MM
    Environ Mol Mutagen; 1997; 29(1):28-35. PubMed ID: 9020304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.